AGN News and Press, Allergan plc From 11/10/19

What's better than a stock that pays great dividends? A stock that pays great dividends and keeps hiking those dividends. That's exactly what AbbVie (NYSE: ABBV) has done since being spun off from Abbott Labs in 2013, raising its dividend every year. If you count the period when AbbVie ...

The manufacturer’s textured products are linked to large cell lymphoma Allergan, the manufacturers of BIOCELL textured “gummy” breast implants, is the target of a proposed national class-action lawsuit by consumer-rights law firm FeganScott. The suit claims that al...

Musings October was especially nice for home gamers like myself (record market highs AND many online brokerages eliminating stock trading fees). I was certainly busy with a month of repositioning my portfolio to skew even more conservatively amidst the new price highs (but yawn-worthy econ...

Merger activity increased for the third week in a row with five new deals announced and ten deals closing. Four out of the five deals announced last week were valued at over $2 billion and two of them were rumored to be in the works before the actual announcement. Deal Statistics: New D...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . SoftBank's first quarterly loss in 14 years is putting a spotlight on founder Masayoshi Son's high-risk approach of investing in ...

Some pharmaceutical stocks might be struggling somewhat in 2019, but not Allergan (NYSE: AGN) . Its shares are up more than 30% so far this year, with a big boost coming from AbbVie 's decision to acquire Allergan . Allergan announced its third-quarter results before the market opened on...

Stocks were set to open higher on Tuesday, following a record close in the previous session, as investors grew more bullish on a potential U.S.-China trade deal as both sides consider more rollbacks in tariffs. Futures for the Dow Jones Industrials gained 79 points, or 0.3%, early Tuesd...

Allergan (NYSE: AGN ) Q3 results : More news on: Allergan plc, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Allergan (NYSE: AGN ): Q3 Non-GAAP EPS of $4.25 beats by $0.05 ; GAAP EPS of -$2.40 misses by $2.82 . Revenue of $4.05B (+3.6% Y/Y) beats by $170M . Shares +0.6% PM. Press Release More news on: Allergan plc, Earnings news and commentary, Healthcare stocks news,

Source: ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...